Screening for Peripheral Vascular Stiffness in Lipedema Patients by Automatic Electrocardiogram-Based Oscillometric Detection.
Adrian MahlmannYazan KhorzomChristian-Alexander BehrendtJennifer Lynne LeipMartin BachlerSiegfried WassertheurerNesma ElzanatyTamer GhazyPublished in: Sensors (Basel, Switzerland) (2024)
Body mass index (BMI) is seen as a predictor of cardiovascular disease (CVD) in lipedema patients. A valid predictor of CVD is increased aortic stiffness (IAS), and previous research described IAS in lipedema. However, it is not known if this applies to all patients. In this cross-sectional single-center cohort study, peripheral pulse wave velocity (PWV) as a non-invasive indicator of aortic stiffness was measured in 41 patients with lipedema, irrespective of stage and without pre-existing cardiovascular conditions or a history of smoking and a maximum body mass index (BMI) of 35 kg/m 2 . Automatically electrocardiogram-triggered oscillometric sensor technology by the Gesenius-Keller method was used. Regardless of the stage of lipedema disease, there was no significant difference in PWV compared to published standard values adjusted to age and blood pressure. BMI alone is not a predictor of cardiovascular risk in lipedema patients. Measuring other anthropometric factors, such as the waist-hip ratio or waist-height ratio, should be included, and the existing cardiovascular risk factors, comorbidities, and adipose tissue distribution for accurate risk stratification should be taken into account. Automated sensor technology recording the PWV represents a valid and reliable method for health monitoring and early detection of cardiovascular risks.
Keyphrases
- body mass index
- end stage renal disease
- cardiovascular disease
- blood pressure
- adipose tissue
- newly diagnosed
- cardiovascular risk factors
- chronic kidney disease
- healthcare
- prognostic factors
- peritoneal dialysis
- type diabetes
- randomized controlled trial
- public health
- skeletal muscle
- heart failure
- high resolution
- physical activity
- insulin resistance
- risk assessment
- weight loss
- quantum dots
- smoking cessation
- patient reported
- glycemic control